100 Participants NeededMy employer runs this trial

H22 for Habits

MQ
Overseen ByMatthew Quitto II
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Dream Video LLC
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

H22 - Unconscious Mind Training and Memory Encoding

Phase I

The core problem this clinical trial, H22, seeks to address is the pervasive challenge of modifying deeply ingrained, often unconscious, unwanted behaviors within the general population. Many individuals struggle with habits or actions that negatively impact quality of life, productivity, or well-being, yet conventional methods often fall short due to the unconscious nature of these behaviors.

Specifically, the trial aims to investigate the efficacy of H22, a novel intervention designed to engage and train the unconscious mind, in mitigating these unwanted behaviors. The central hypothesis guiding this research is that H22 training will empower volunteers to significantly reduce the frequency and intensity of identified unwanted behaviors.

Who Is on the Research Team?

MQ

Matthew Quitto II

Principal Investigator

Dream Video LLC

Are You a Good Fit for This Trial?

This trial is for adults who can read and write, and are willing to follow the study instructions. It's aimed at people wanting help with unwanted habits or behaviors that affect their daily life.

Inclusion Criteria

Can read and write
Willing and able to follow the requirements of the protocol

Exclusion Criteria

Medical instability, restlessness, or other factors that would compromise data acquisition

What Are the Treatments Tested in This Trial?

Interventions

  • H22

Trial Overview

The study is testing H22, a new training method designed to work with the unconscious mind to help reduce unwanted behaviors. This is an early-phase (Phase I) trial focused on safety and initial effectiveness.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: H22 #1Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Dream Video LLC

Lead Sponsor

Dream Holdings Research

Collaborator